Cipla plans acquisitions to take top spot in South Africa drug market

The company said the board has also approved the appointment of Kamil Hamied as Non-Executive Director.


Drug major Cipla on Tuesday said MK Hamied has resigned as Vice Chairman with effect from October 29 due to age and health.


“It is with a heavy heart that I write to formally announce my resignation from the position of Vice Chairman and Non-Executive Director of the company,” he said in a letter to the board of directors.


The company said the board has also approved the appointment of Kamil Hamied as Non-Executive Director, with effect November 1, 2024.


“I am pleased to see that Kamil Hamied will be joining the Board as a Non-Executive Director to maintain continuity while representing the promoter family,” MK Hamied said in the letter.

First Published: Sep 03 2024 | 11:27 PM IST



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts